Daniel Solove writes: A recent article in The Atlantic discusses the risk of 23andMe selling its vast stockpile of DNA data on 15 million individuals: 23andMe is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week,…
NY Mets used facial recognition to profit on unsuspecting Citi Field fans: suit
Dean Balsamini reports: Here’s one New Yorker who is not jumping on the Mets’ bandwagon. The team uses facial recognition technology to collect information on unsuspecting Citi Field patrons, claims Chris Dowling in a new class-action lawsuit. Citi Field cameras “at the main fan entrance” collect “facial identifiers” from patrons as they enter the stadium,…
Women’s Health on the Ballot in November: What the Election Could Mean for Reproductive Care and Beyond
Amanda Zablocki, Elizabeth A. Nevins, Arushi Pandya, and Krysten Thomas of SheppardMullin write: Over two years into the post-Dobbs era, women’s health is taking center stage in the presidential election. In Dobbs v. Jackson, the Supreme Court overturned protections relating to abortion established in Roe v. Wade. Since then, approximately half of the states across the country have enacted…
UK: New data protection audit framework launched to help organisations improve compliance
From the Information Commissioner’s Office: We have today launched a new audit framework designed to help organisations assess their own compliance with key requirements under data protection law. The framework empowers organisations to identify necessary steps to improve their data protection practices and create a culture of compliance. It provides them with a starting point to evaluate how…